Form EFFECT GT Biopharma, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 13, 2026 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shanghai - New York: to Become a Benchmark for China-U.S. Subnational Cooperation
- Chu Hai Bang (Shenzhen) Technology Co., Ltd. Launches Vibeperk Global Low-Price Shopping Mall, Delivers Cheaper Authentic Merchandise Than Amazon Across Global Markets
- Avinci Wealth Management Announces "The New Rules of Wealth," Introducing a Coordinated Retirement Planning Framework for Affluent Families
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share